BioSpace News Archive

Policy

Synlogic Granted Fast Track Designation from FDA for labafenogene marselecobac (SYNB1934) for Treatment of Phenylketonuria

Synlogic, Inc. announced that the U.S. Food and Drug Administration has granted Fast Track designation to labafenogene marselecobac for the treatment of phenylketonuria.

July 11, 2023
·
5 min read
BioMidwest

AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer

AccuStem Sciences, Inc., a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, signs further agreement with the IEO, one of the most renowned comprehensive cancer centers in Europe.

July 11, 2023
·
6 min read
BioMidwest

Monopar Announces MNPR-101 Radiopharma Collaboration Agreement with National University of Singapore

Monopar Therapeutics Inc. announced a collaboration with the Cancer Science Institute of Singapore at the National University of Singapore to evaluate radiopharmaceutical versions of MNPR-101 in several aggressive cancers.

July 11, 2023
·
5 min read
Samsung Bioepis Releases its Second US Biosimilar Market Report

Samsung Bioepis Co., Ltd. released the second edition of its Biosimilar Market Report which explores latest market trends for all biosimilars commercially available in the United States.

July 11, 2023
·
1 min read
Business

Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2

Bausch + Lomb Corporation, a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2023 financial results on Wednesday, Aug. 2, 2023.

July 11, 2023
·
1 min read
Business

Verastem Oncology Announces Promotion of Dan Paterson to Chief Executive Officer

Verastem Oncology (Nasdaq: VSTM) (the “Company”), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced today that Dan Paterson, President and Chief Operating Officer, has been promoted to President and Chief Executive Officer (CEO).

July 11, 2023
·
8 min read
Business

Sampled Named a Certified Service Provider for PacBio

Sampled today announced that it has been named a Certified Service Provider for PacBio, a leading developer of high-quality, highly accurate sequencing solutions, equipping Sampled to deliver the highest quality advanced sequencing technology services on PacBio’s technology.

July 11, 2023
·
2 min read
Genetown

Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Receptors to Treat Cancer

Crossbow Therapeutics, Inc. today announced an $80 million Series A funding round led by MPM BioImpact and Pfizer Ventures, with participation from Polaris Partners, BVF Partners, Eli Lilly and Company, Mirae Asset Venture Investment, and Mirae Asset Capital.

July 11, 2023
·
3 min read
Drug Development

Cognition Therapeutics Announces Dosing of First Patient in MAGNIFY Study of Oral CT1812 for Geographic Atrophy Secondary to Dry AMD

Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that it has dosed the first participant in the Phase 2 MAGNIFY study of CT1812, an experimental therapy being developed for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (dry AMD).

July 11, 2023
·
7 min read
Pharm Country

Sybleu Inc. Purchases Fifty Percent Stake In Patent Protected Small Molecule Therapeutic Compounds, Anticipates Synergy With Recently In-Licensed AI/ML Engine

SYBLEU INC. is preparing to begin advancing small molecule drug therapies for animal and human health.

July 11, 2023
·
3 min read